Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Location

MS status

Recruitment Status

Phase

Drugs

Prior Immunotherapy Allowed

NCT ID

Title key word search

Date Trial Added

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Phase	Date Added	Location	Prior IO Allowed	CRC-directed	Status	Drugs	Tags
NCT ID NCT06152523	TitleMonalizumab and MEDI5752 in Patients With MSI and/or dMMR Metastatic Cancer	Phase Phase 2	Date Added 2023-11-30	Location France	Prior IO Allowed No	CRC-directed Yes	Status Not yet recruiting	Drugs Monalizumab/MEDI5257	Tags MSI-H/ MMRd
NCT ID NCT02285816	TitleMG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine With Transgenic MAGE-A3 Insertion in Incurable MAGE-A3-Expressing Solid Tumours	Phase Phase 1, Phase 2	Date Added 2014-11-07	Location Canada	Prior IO Allowed Yes	CRC-directed No	Status Active, not recruiting	Drugs AdMA3, MG1MA3	Tags MSS/ MMRp
NCT ID NCT03388190	TitleMETIMMOX: Colorectal Cancer METastasis – Shaping Anti-tumor IMMunity by OXaliplatin	Phase Phase 2	Date Added 2018-01-02	Location Norway	Prior IO Allowed No	CRC-directed Yes	Status Active, not recruiting	Drugs FLOX, Nivolumab, Opdivo	Tags MSS/ MMRp
NCT ID NCT03925662	TitleMebendazole as Adjuvant Treatment for Colon Cancer	Phase Phase 3	Date Added 2019-04-24	Location Egypt	Prior IO Allowed No	CRC-directed Yes	Status Recruiting	Drugs Folfox with avastin, Mebendazole	Tags MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT06514651	TitleMAQ-001 in Patients With Advanced Solid Tumors	Phase Phase 1	Date Added 2024-07-23	Location France	Prior IO Allowed Yes	CRC-directed No	Status Recruiting	Drugs	Tags MSI-H/ MMRd
NCT ID NCT05286814	TitleM9241 in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer or Intrahepatic Cholangiocarcinoma	Phase Phase 2	Date Added 2022-03-18	Location Maryland, United States	Prior IO Allowed No	CRC-directed Yes	Status Recruiting	Drugs	Tags MSS/ MMRp
NCT ID NCT04874259	TitleLT for Unresectable Colorectal Liver Metastasis	Phase Not Applicable	Date Added 2021-05-05	Location Korea, Republic of	Prior IO Allowed No	CRC-directed Yes	Status Recruiting	Drugs	Tags MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT06310564	TitleLow and Intermediate Risk oliGometastatic coloREctal cancEr patieNts Treated With Stereotactic ABlative Radiotherapy	Phase Not Applicable	Date Added 2024-03-15	Location Italy	Prior IO Allowed Yes	CRC-directed Yes	Status Recruiting	Drugs	Tags MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT04062721	TitleLocal Immunomodulation After Radiofrequency of Unresectable Colorectal Liver Metastases	Phase Phase 1	Date Added 2019-08-20	Location France	Prior IO Allowed Yes	CRC-directed Yes	Status Not yet recruiting	Drugs Chemotherapy, In situ immunotherapy	Tags MSS/ MMRp
NCT ID NCT03488953	TitleLiving Donor Liver Transplantation With Two Stage Hepatectomy for Patients With Isolated, Irresectable Colorectal Liver Metastases	Phase Not Applicable	Date Added 2018-04-05	Location Germany	Prior IO Allowed No	CRC-directed Yes	Status Recruiting	Drugs	Tags MSI-H/ MMRd, MSS/ MMRp

Showing 131 to 140 of 299 entries